The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral

A C Dijkmans1, D M Kweekel, C Balmforth

  • 1Centre for Human Drug Research, Leiden, the Netherlands.

Abstract

Insights

A simplified oral absorption test (OAT) effectively identifies patients who can continue oral flucloxacillin treatment for Staphylococcus aureus infections. This method avoids IV interruption, improving clinical management of antibiotic therapy.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Severe methicillin-sensitive Staphylococcus aureus infections are preferably treated with flucloxacillin.
  • Variable oral absorption of flucloxacillin leads clinicians to use broader-spectrum antibiotics.
  • Classical oral absorption tests (OAT) are laborious and require IV therapy interruption.

Purpose of the Study:

  • To investigate the utility of a simplified OAT in a clinical setting.
  • To guide antibiotic treatment decisions for severe S. aureus infections.
  • To assess if a simplified OAT can enable continuation of oral flucloxacillin therapy.

Main Methods:

  • A simplified OAT (test B) was compared to a classical OAT (test A) in 196 patients receiving IV flucloxacillin.
  • 1g oral flucloxacillin was administered after a one-hour fast, with serum samples collected at 0, 1, and 2 hours.
  • Flucloxacillin concentrations were measured using high-performance liquid chromatography; adequate absorption was defined as a ≥10 mg/l increase from baseline.

Main Results:

  • No significant difference in maximal flucloxacillin absorption increase was observed between the simplified OAT (21.5 mg/l) and classical OAT (22.0 mg/l).
  • 13% of patients showed inadequate oral flucloxacillin absorption.
  • Absorption levels were not correlated with age, creatinine, or albumin, and showed no gender differences.

Conclusions:

  • The simplified OAT is a viable tool for assessing oral flucloxacillin absorption in clinical practice.
  • This simplified test facilitates the identification of patients suitable for continued oral small-spectrum antibiotic therapy.
  • It supports effective management of severe S. aureus infections by enabling oral flucloxacillin use.

Related Concept Videos

Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
542
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
597
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
126
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K